Long-term response to lithium salts in bipolar illness is influenced by the glycogen synthase kinase 3-β -50 T/C SNP

Neuroscience Letters

Volumn 376, Issue 1, 2005, Pages 51-55

  Benedetti, Francesco ^a,b   Serretti, Alessandro ^a,b   Pontiggia, Adriana ^b   Bernasconi, Alessandro ^b   Lorenzi, Cristina ^a   Colombo, Cristina ^a,b   Smeraldi, Enrico ^a,b  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Age at onset; Bipolar disorder; Endophenotype; Glycogen synthase kinase 3 ; Lithium; Sleep deprivation

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3BETA; LITHIUM SALT;

ADULT; ALLELE; ARTICLE; BIPOLAR I DISORDER; CONTROLLED STUDY; DRUG TARGETING; FEMALE; HOMOZYGOTE; HUMAN; INSTRUMENT STERILIZATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; RECURRENT DISEASE; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 13444269371     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2004.11.022     Document Type: Article

References (28)

1. R.F. Badenhop, M.J. Moses, A. Scimone, P.B. Mitchell, K.R. Ewen-White, A. Rosso, J.A. Donald, L.J. Adams, and P.R. Schofield A genome screen of 13 bipolar affective disorder pedigrees provides evidence for susceptibility loci on chromosome 3 as well as chromosomes 9, 13 and 19 Mol. Psychiatry 7 2002 851 859
2. J.M. Beaulieu, T.D. Sotnikova, W.D. Yao, L. Kockeritz, J.R. Woodgett, R.R. Gainetdinov, and M.G. Caron Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade Proc. Natl. Acad. Sci. U.S.A. 101 2004 5099 5104
3. F. Benedetti, A. Serretti, C. Colombo, C. Lorenzi, V. Tubazio, and E. Smeraldi A glycogen synthase kinase 3-β promoter gene SNP is associated with age at onset and response to total sleep deprivation in bipolar depression Neurosci. Lett. 368 2 2004 123 126
4. F. Benedetti, A. Bernasconi, C. Lorenzi, A. Pontiggia, A. Serretti, C. Colombo, and E. Smeraldi A single nucleotide polymorphism in glycogen synthase kinase 3-beta promoter gene influences onset of illness in patients affected by bipolar disorder Neurosci. Lett. 355 2004 37 40
5. F. Bosch, A.M. Gomez-Foix, J. Arino, and J.J. Guinovart Effects of lithium ions on glycogen synthase and phosphorylase in rat hepatocytes J. Biol. Chem. 261 1986 16927 16931
6. A.C. Chen, Y. Shirayama, K.H. Shin, R.L. Neve, and R.S. Duman Expression of the cAMP response element binding protein (CREB) in hippocampus produces an antidepressant effect Biol. Psychiatry 49 2001 753 762
7. L. Franchini, R. Zanardi, E. Smeraldi, and M. Gasperini Early onset of lithium prophylaxis as a predictor of good long-term outcome Eur. Arch. Psychiatry Clin. Neurosci. 249 1999 227 230
8. P. Gasparini, X. Estivill, V. Volpini, A. Totaro, S. Castellvi-Bel, N. Govea, M. Mila, M. Della Monica, V. Ventruto, M. De Benedetto, P. Stanziale, L. Zelante, E.S. Mansfield, L. Sandkuijl, S. Surrey, and P. Fortina Linkage of DFNB1 to non-syndromic neurosensory autosomal-recessive deafness in Mediterranean families Eur. J. Hum. Genet. 5 1997 83 88
9. C.A. Grimes, and R.S. Jope The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling Prog. Neurobiol. 65 2001 391 426
10. L. Hansen, K.C. Arden, S.B. Rasmussen, C.S. Viars, H. Vestergaard, T. Hansen, A.M. Moller, J.R. Woodgett, and O. Pedersen Chromosomal mapping and mutational analysis of the coding region of the glycogen synthase kinase-3alpha and beta isoforms in patients with NIDDM Diabetologia 40 1997 940 946
11. A.J. Harwood, and G. Agam Search for a common mechanism of mood stabilizers Biochem. Pharmacol. 66 2003 179 189
12. E. Iwahana, M. Akiyama, K. Miyakawa, A. Uchida, J. Kasahara, K. Fukunaga, T. Hamada, and S. Shibata Effect of lithium on the circadian rhythms of locomotor activity and glycogen synthase kinase-3 protein expression in the mouse suprachiasmatic nuclei Eur. J. Neurosci. 19 2004 2281 2287
13. R.S. Jope, and G.V. Johnson The glamour and gloom of glycogen synthase kinase-3 Trends Biochem. Sci. 29 2004 95 102
14. O. Kaidanovich-Beilin, A. Milman, A. Weizman, C.G. Pick, and H. Eldar-Finkelman Rapid antidepressive-like activity of specific glycogen synthase kinase-3 inhibitor and its effect on β-catenin in mouse hippocampus Biol. Psychiatry 55 2004 781 784
15. P.S. Klein, and D.A. Melton A molecular mechanism for the effect of lithium on development Proc. Natl. Acad. Sci. U.S.A. 93 1996 8455 8459
16. H. Klemfuss Rhythms and the pharmacology of lithium Pharmacol. Ther. 56 1992 53 78
17. H. Klemfuss, and D.F. Kripke Antimanic drugs stabilize hamster circadian rhythms Psychiatry Res. 57 1995 215 222
18. K.F. Lau, C.C. Miller, B.H. Anderton, and P.C. Shaw Expression analysis of glycogen synthase kinase-3 in human tissues J. Pept. Res. 54 1999 85 91
19. K.F. Lau, C.C. Miller, B.H. Anderton, and P.C. Shaw Molecular cloning and characterization of the human glycogen synthase kinase-3beta promoter Genomics 60 1999 121 128
20. R.H. Lenox, T.D. Gould, and H.K. Manji Endophenotypes in bipolar disorder Am. J. Med. Gen. 114 2002 391 406
21. M. Lesort, A. Greendorfer, C. Stockmeier, G.V. Johnson, and R.S. Jope Glycogen synthase kinase-3beta, beta-catenin, and tau in postmortem bipolar brain J. Neural. Transm. 106 1999 1217 1222
22. L. Mai, R.S. Jope, and X. Li BDNF-mediated signal transduction is modulated by GSK3beta and mood stabilizing agents J. Neurochem. 82 2002 75 83
23. S. Martinek, S. Inonog, A.S. Manoukian, and M.W. Young A role for the segment polarity gene shaggy/GSK3-β in the Drosophila circadian clock Cell 105 2001 769 779
24. S.S. Newton, J. Thome, T.L. Wallace, Y. Shirayama, L. Schlesinger, and N. Sakai Inhibition of cAMP response element-binding protein or dynorphin in the nucleus accumbens produces an antidepressant-like effect J. Neurosci. 22 2002 10883 10890
25. W.T. O'Brien, A.D. Harper, F. Jove, J.R. Woodgett, S. Maretto, S. Piccolo, and P.S. Klein Glycogen synthase kinase-3beta haploinsufficiency mimics the behavioral and molecular effects of lithium J. Neurosci. 24 2004 6791 6798
26. C. Russ, S. Lovestone, and J.F. Powell Identification of sequence variants and analysis of the role of the glycogen synthase kinase 3 beta gene and promoter in late onset Alzheimer's disease Mol. Psychiatry 6 2001 320 324
27. A. Serretti, and P. Artioli Predicting response to lithium in mood disorders: role of genetic polymorphisms Am. J. Pharmacogenomics 3 2003 17 30
28. P. Vestergaard, R.W. Licht, A. Brodersen, N.A. Rasmussen, H. Christensen, T. Arngrim, B. Gronvall, E. Kristensen, and I. Poulstrup Outcome of lithium prophylaxis - a prospective follow-up of affective disorder patients assigned to high and low serum lithium levels Acta Psychiatrica. Scand. 98 1998 310 315